Clinical trial
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
NCT00306995 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00306995 |
|---|---|
| Title | Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population |
| Official title | A Phase III, Open, Randomized, Multicenter, Comparative Vaccination Study to Evaluate the Immunogenicity and Reactogenicity of Various Formulations of a Monovalent Candidate Pandemic Influenza A Vaccine in Individuals Over 60 Years of Age |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza, Influenza Vaccines |
| Intervention type | Biological |
| Interventions | SB218352_15, SB218352_8, SB218352_4, SB218352_2, SB218352_8AL, SB218352_4AL, SB218352_2AL |
| Enrollment | 385 |
| Start date | May 11, 2005 |
| Primary completion | Jul 4, 2006 |
| Completion | Jul 4, 2006 |
| First posted | Mar 27, 2006 |
| Last update posted | Feb 10, 2020 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: